UniProt O58441
Serine--tRNA ligase (O58441)
Serine--tRNA ligase (UniProt O58441): 6 experimental structures and 1 predicted model on GenesisL1, 3 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- O58441
- Protein
- Serine--tRNA ligase
- Experimental structures
- 6
- Predicted models
- 1
- Pockets
- 3 · 1 record with a druggable one
Structures
7 records of O58441 in the MolNFT archive: 6 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2DQ0 | Crystal structure of seryl-tRNA synthetase from Pyrococcus horikoshii complexed with a… | x-ray diffraction | A, B | — | — |
| 2DQ0 | Crystal structure of seryl-tRNA synthetase from pyrococcus horikoshii complexed with a… | x-ray diffraction | A, B | — | — |
| 2ZR2 | Crystal structure of seryl-tRNA synthetase from Pyrococcus horikoshii complexed with ATP | x-ray diffraction | A, B | — | — |
| 2ZR2 | Crystal structure of seryl-tRNA synthetase from pyrococcus horikoshii complexed with ATP | x-ray diffraction | A, B | — | — |
| 2ZR3 | Crystal structure of seryl-tRNA synthetase from Pyrococcus horikoshii | x-ray diffraction | A, B | — | — |
| 2ZR3 | Crystal structure of seryl-tRNA synthetase from pyrococcus horikoshii | x-ray diffraction | A, B | — | — |
| O58441 | AlphaFold monomer V2.0 prediction for serine--tRNA ligase (O58441) | predicted | A | — | 3 (best 0.73) |
Experiment against prediction
- 2DQ0 chain A against the predicted model O58441: TM-score 0.98, RMSD 1.35 Å
- 2DQ0 chain A against the predicted model O58441: TM-score 0.98, RMSD 1.35 Å
- 2ZR3 chain A against the predicted model O58441: TM-score 0.97, RMSD 1.45 Å
- 2ZR3 chain A against the predicted model O58441: TM-score 0.97, RMSD 1.45 Å
- 2ZR2 chain A against the predicted model O58441: TM-score 0.97, RMSD 1.45 Å
- 2ZR2 chain A against the predicted model O58441: TM-score 0.97, RMSD 1.45 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.